28th Mar 2008 17:00
GlaxoSmithKline PLC28 March 2008 Issued - Friday 28th March 2008 GlaxoSmithKline plc Announces Changes to Board Committee The Board has appointed Mr H Lawrence Culp and Sir Robert Wilson members of the Nominations Committee with immediate effect. A table showing the membership of the Board and its committees is attached. S M BicknellCompany Secretary28th March 2008 ________________________ Board and Committee Membership with effect from 28th March 2008 Sir Christopher Gent ChairmanSir Ian Prosser Senior Independent Non-Executive Director Dr J-P Garnier Chief Executive OfficerMr Andrew Witty Executive Director, Chief Executive Officer DesignateMr Julian S Heslop Chief Financial OfficerDr Moncef Slaoui Executive Director, Chairman, Research & DevelopmentMr Chris Viehbacher Executive Director, President, US Pharmaceuticals Professor Sir Roy Anderson Independent Non-Executive DirectorDr Stephanie Burns Independent Non-Executive DirectorMr H Lawrence Culp Independent Non-Executive DirectorSir Crispin Davis Independent Non-Executive DirectorSir Deryck Maughan Independent Non-Executive DirectorDr Dan Podolsky Independent Non-Executive DirectorDr Ronaldo Schmitz Independent Non-Executive DirectorMr Tom De Swaan Independent Non Executive DirectorSir Robert Wilson Independent Non-Executive Director Board Committee Committee Chairman Members Audit Mr Tom De Swaan Sir Deryck Maughan Dr Dan Podolsky Sir Ian Prosser Dr Ronaldo Schmitz Sir Robert Wilson Remuneration Sir Robert Wilson Mr H Lawrence Culp Sir Crispin Davis Sir Christopher Gent Dr Ronaldo Schmitz Nominations Sir Christopher Gent Mr H Lawrence Culp Sir Ian Prosser Dr Ronaldo Schmitz Sir Robert Wilson Corporate Responsibility Sir Christopher Gent Dr Stephanie Burns Sir Ian Prosser Dr Dan Podolsky Mr Tom de Swaan This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline